N

Neuland Laboratories Ltd

Pharmaceuticals

SMALLCAP

Pharmaceuticals

Live Performance vs 

This is a tool to communicate factual return information and should not be seen as an advertisement or promotion

Analyst Ratings and Key Metrics

Based on 2 analysts offering recommendations for Neuland Laboratories Ltd

100%

Buy

0%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio51.6451.22
PB Ratio12.086.55
Dividend Yield0.12%0.48%

Understand what these metrics mean. 

About the company

N

Neuland Laboratories Ltd

Neuland Laboratories Limited is engaged in manufacturing active pharmaceutical ingredient (API). The Company also provides custom manufacturing solutions (CMS) to develop and manufacture pharmaceutical ingredie...
Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions